Update: Capecitabine Warnings from NHS England

Both Macmillan (regimen patient information sheets) and CRUK (regimen specific consent forms) are updating their capecitabine containing documents to reference the warnings on Toxic Epidermal Necrolysis (TEN) and Stevens Johnson Syndrome(SJS)’ that NHS England commissioners have asked all providers (England) to ensure are made known to patients.   The updates to these documents will make it much easier for chemotherapy services to reply.   The updated documents should be available in next couple of weeks.

Thanks to all who have been involved in the speedy response.    

Latest News

By BOPA E&T Subcommittee on 9th December 2025

BOPA Introduction to Cancer Course, Scotland, March 2026 – registration now OPEN!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By BOPA Research Committee on 7th December 2025

BOPA-PRUK Research Award – NOW OPEN for Applications 2026

The 2026 PRUK funding round launched on 24th November 2025 and will close at 1pm on 25th March 2026.  BOPA-PRUK Research Award – NOW OPEN for Applications 2026 This award provides pharmacy professionals…

Read article
By BOPA Research Subcommittee on 2nd December 2025

AI in Oncology Survey

The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…

Read article
By BOPA Research Sub Committee on 2nd December 2025

Project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services

Dear Colleagues, The University of Birmingham and University Hospitals Birmingham are jointly conducting a project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services. We…

Read article